Zheng Wang1, Debby Koonen, Marten Hofker, Jingyuan Fu. 1. aDepartment of Geriatrics and Gastroenterology, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai, P.R. China bDepartment of Paediatrics, Molecular Genetics cDepartment of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands *Zheng Wang and Debby Koonen contributed equally to the writing of this article.
Abstract
PURPOSE OF REVIEW: The gut microbiome has now been convincingly linked to human metabolic health but the underlying causality and mechanisms remain poorly understood. This review focuses on the recent progress in establishing the associations between gut microbiome species and lipid metabolism in humans and discusses how to move from association toward causality and mechanistic understanding, which is essential knowledge to bring the observed associations into clinical use. RECENT FINDINGS: Recent population-based association studies have shown that the gut microbiota composition can explain a substantial proportion of the interindividual variation in blood triglycerides and HDL-cholesterol level and predict metabolic response to diet and drug. Faecal transplantation has suggested that this is a causal effect of microbiome on host metabolism, although the underlying mechanism remains largely unexplored. SUMMARY: The gut microbiome is transitioning from being a 'missing' organ to a potential target for therapeutic applications. Due to the complex interplay between the gut microbiome, the host genome, and diet, a systematic approach is required to pave the way for therapeutic development.
PURPOSE OF REVIEW: The gut microbiome has now been convincingly linked to human metabolic health but the underlying causality and mechanisms remain poorly understood. This review focuses on the recent progress in establishing the associations between gut microbiome species and lipid metabolism in humans and discusses how to move from association toward causality and mechanistic understanding, which is essential knowledge to bring the observed associations into clinical use. RECENT FINDINGS: Recent population-based association studies have shown that the gut microbiota composition can explain a substantial proportion of the interindividual variation in blood triglycerides and HDL-cholesterol level and predict metabolic response to diet and drug. Faecal transplantation has suggested that this is a causal effect of microbiome on host metabolism, although the underlying mechanism remains largely unexplored. SUMMARY: The gut microbiome is transitioning from being a 'missing' organ to a potential target for therapeutic applications. Due to the complex interplay between the gut microbiome, the host genome, and diet, a systematic approach is required to pave the way for therapeutic development.
Authors: Peter J H Jones; Maryam Shamloo; Dylan S MacKay; Todd C Rideout; Semone B Myrie; Jogchum Plat; Jean-Baptiste Roullet; David J Baer; Kara L Calkins; Harry R Davis; P Barton Duell; Henry Ginsberg; Helena Gylling; David Jenkins; Dieter Lütjohann; Mohammad Moghadasian; Robert A Moreau; David Mymin; Richard E Ostlund; Rouyanne T Ras; Javier Ochoa Reparaz; Elke A Trautwein; Stephen Turley; Tim Vanmierlo; Oliver Weingärtner Journal: Nutr Rev Date: 2018-10-01 Impact factor: 7.110
Authors: Natalia S Klimenko; Alexander V Tyakht; Anna S Popenko; Anatoly S Vasiliev; Ilya A Altukhov; Dmitry S Ischenko; Tatiana I Shashkova; Daria A Efimova; Dmitri A Nikogosov; Dmitrii A Osipenko; Sergey V Musienko; Kseniya S Selezneva; Ancha Baranova; Alexander M Kurilshikov; Stepan M Toshchakov; Aleksei A Korzhenkov; Nazar I Samarov; Margarita A Shevchenko; Alina V Tepliuk; Dmitry G Alexeev Journal: Nutrients Date: 2018-05-08 Impact factor: 5.717
Authors: Jeannot F Zinsou; Jacqueline J Janse; Yabo Y Honpkehedji; Jean Claude Dejon-Agobé; Noemí García-Tardón; Pytsje T Hoekstra; Marguerite Massinga-Loembe; Paul L A M Corstjens; Govert J van Dam; Martin Giera; Peter G Kremsner; Maria Yazdanbakhsh; Ayola A Adegnika; Bruno Guigas Journal: PLoS Negl Trop Dis Date: 2020-07-02
Authors: Janelle E Stanton; Sigita Malijauskaite; Kieran McGourty; Andreas M Grabrucker Journal: Front Mol Neurosci Date: 2021-07-05 Impact factor: 5.639
Authors: Loek P Smits; Ruud S Kootte; Evgeni Levin; Andrei Prodan; Susana Fuentes; Erwin G Zoetendal; Zeneng Wang; Bruce S Levison; Maartje C P Cleophas; E Marleen Kemper; Geesje M Dallinga-Thie; Albert K Groen; Leo A B Joosten; Mihai G Netea; Erik S G Stroes; Willem M de Vos; Stanley L Hazen; Max Nieuwdorp Journal: J Am Heart Assoc Date: 2018-03-26 Impact factor: 5.501